ID   NWD1_HUMAN              Reviewed;        1564 AA.
AC   Q149M9; C9J021; Q68CT3;
DT   23-OCT-2007, integrated into UniProtKB/Swiss-Prot.
DT   30-NOV-2010, sequence version 3.
DT   03-MAY-2023, entry version 126.
DE   RecName: Full=NACHT domain- and WD repeat-containing protein 1;
GN   Name=NWD1;
OS   Homo sapiens (Human).
OC   Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia;
OC   Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae;
OC   Homo.
OX   NCBI_TaxID=9606;
RN   [1]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 3), AND VARIANTS GLY-174;
RP   THR-218 AND ILE-926.
RC   TISSUE=Amygdala;
RX   PubMed=17974005; DOI=10.1186/1471-2164-8-399;
RA   Bechtel S., Rosenfelder H., Duda A., Schmidt C.P., Ernst U.,
RA   Wellenreuther R., Mehrle A., Schuster C., Bahr A., Bloecker H., Heubner D.,
RA   Hoerlein A., Michel G., Wedler H., Koehrer K., Ottenwaelder B., Poustka A.,
RA   Wiemann S., Schupp I.;
RT   "The full-ORF clone resource of the German cDNA consortium.";
RL   BMC Genomics 8:399-399(2007).
RN   [2]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE GENOMIC DNA].
RX   PubMed=15057824; DOI=10.1038/nature02399;
RA   Grimwood J., Gordon L.A., Olsen A.S., Terry A., Schmutz J., Lamerdin J.E.,
RA   Hellsten U., Goodstein D., Couronne O., Tran-Gyamfi M., Aerts A.,
RA   Altherr M., Ashworth L., Bajorek E., Black S., Branscomb E., Caenepeel S.,
RA   Carrano A.V., Caoile C., Chan Y.M., Christensen M., Cleland C.A.,
RA   Copeland A., Dalin E., Dehal P., Denys M., Detter J.C., Escobar J.,
RA   Flowers D., Fotopulos D., Garcia C., Georgescu A.M., Glavina T., Gomez M.,
RA   Gonzales E., Groza M., Hammon N., Hawkins T., Haydu L., Ho I., Huang W.,
RA   Israni S., Jett J., Kadner K., Kimball H., Kobayashi A., Larionov V.,
RA   Leem S.-H., Lopez F., Lou Y., Lowry S., Malfatti S., Martinez D.,
RA   McCready P.M., Medina C., Morgan J., Nelson K., Nolan M., Ovcharenko I.,
RA   Pitluck S., Pollard M., Popkie A.P., Predki P., Quan G., Ramirez L.,
RA   Rash S., Retterer J., Rodriguez A., Rogers S., Salamov A., Salazar A.,
RA   She X., Smith D., Slezak T., Solovyev V., Thayer N., Tice H., Tsai M.,
RA   Ustaszewska A., Vo N., Wagner M., Wheeler J., Wu K., Xie G., Yang J.,
RA   Dubchak I., Furey T.S., DeJong P., Dickson M., Gordon D., Eichler E.E.,
RA   Pennacchio L.A., Richardson P., Stubbs L., Rokhsar D.S., Myers R.M.,
RA   Rubin E.M., Lucas S.M.;
RT   "The DNA sequence and biology of human chromosome 19.";
RL   Nature 428:529-535(2004).
RN   [3]
RP   NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORM 2).
RX   PubMed=15489334; DOI=10.1101/gr.2596504;
RG   The MGC Project Team;
RT   "The status, quality, and expansion of the NIH full-length cDNA project:
RT   the Mammalian Gene Collection (MGC).";
RL   Genome Res. 14:2121-2127(2004).
RN   [4]
RP   FUNCTION, INTERACTION WITH HSP90AA1; HSP90AB1 AND BAG2, SUBCELLULAR
RP   LOCATION, TISSUE SPECIFICITY, AND INDUCTION BY SOX9 AND SRY.
RX   PubMed=24681825; DOI=10.18632/oncotarget.1850;
RA   Correa R.G., Krajewska M., Ware C.F., Gerlic M., Reed J.C.;
RT   "The NLR-related protein NWD1 is associated with prostate cancer and
RT   modulates androgen receptor signaling.";
RL   Oncotarget 5:1666-1682(2014).
CC   -!- FUNCTION: May play a role in the control of androgen receptor (AR)
CC       protein steady-state levels. {ECO:0000269|PubMed:24681825}.
CC   -!- SUBUNIT: May interact with HSP90AA1, HSP90AB1 and BAG2.
CC       {ECO:0000269|PubMed:24681825}.
CC   -!- SUBCELLULAR LOCATION: Cytoplasm, cytosol {ECO:0000269|PubMed:24681825}.
CC   -!- ALTERNATIVE PRODUCTS:
CC       Event=Alternative splicing; Named isoforms=3;
CC       Name=1;
CC         IsoId=Q149M9-1; Sequence=Displayed;
CC       Name=2;
CC         IsoId=Q149M9-2; Sequence=VSP_040651, VSP_040652;
CC       Name=3;
CC         IsoId=Q149M9-3; Sequence=VSP_028940, VSP_028941;
CC   -!- TISSUE SPECIFICITY: Expressed at highest levels in prostate, followed
CC       by testis, retina, trachea and optic nerve. Also detected in brain,
CC       epididymis, lung, vagina and pituitary. In the prostate, tends to be
CC       up-regulated during malignant progression compared to normal epithelium
CC       (at protein level). {ECO:0000269|PubMed:24681825}.
CC   -!- INDUCTION: May be up-regulated by SOX9 and SRY.
CC       {ECO:0000269|PubMed:24681825}.
CC   -!- MISCELLANEOUS: [Isoform 2]: May be produced at very low levels due to a
CC       premature stop codon in the mRNA, leading to nonsense-mediated mRNA
CC       decay. {ECO:0000305}.
CC   -!- SEQUENCE CAUTION:
CC       Sequence=AAI17699.1; Type=Erroneous translation; Note=Wrong choice of CDS.; Evidence={ECO:0000305};
CC   ---------------------------------------------------------------------------
CC   Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms
CC   Distributed under the Creative Commons Attribution (CC BY 4.0) License
CC   ---------------------------------------------------------------------------
DR   EMBL; CR749794; CAH18655.1; -; mRNA.
DR   EMBL; AC008737; -; NOT_ANNOTATED_CDS; Genomic_DNA.
DR   EMBL; BC117698; AAI17699.1; ALT_SEQ; mRNA.
DR   CCDS; CCDS32945.2; -. [Q149M9-3]
DR   RefSeq; NP_001007526.3; NM_001007525.4. [Q149M9-3]
DR   RefSeq; NP_001277284.1; NM_001290355.2.
DR   RefSeq; NP_001334923.1; NM_001347994.1.
DR   RefSeq; XP_011526231.1; XM_011527929.1. [Q149M9-1]
DR   RefSeq; XP_011526232.1; XM_011527930.2. [Q149M9-1]
DR   RefSeq; XP_011526233.1; XM_011527931.2. [Q149M9-1]
DR   AlphaFoldDB; Q149M9; -.
DR   SMR; Q149M9; -.
DR   BioGRID; 129876; 1.
DR   IntAct; Q149M9; 3.
DR   STRING; 9606.ENSP00000428579; -.
DR   iPTMnet; Q149M9; -.
DR   PhosphoSitePlus; Q149M9; -.
DR   BioMuta; NWD1; -.
DR   DMDM; 313104204; -.
DR   EPD; Q149M9; -.
DR   jPOST; Q149M9; -.
DR   MassIVE; Q149M9; -.
DR   PaxDb; Q149M9; -.
DR   PeptideAtlas; Q149M9; -.
DR   ProteomicsDB; 60291; -. [Q149M9-1]
DR   ProteomicsDB; 60293; -. [Q149M9-3]
DR   Antibodypedia; 69163; 8 antibodies from 7 providers.
DR   DNASU; 284434; -.
DR   Ensembl; ENST00000379808.7; ENSP00000369136.3; ENSG00000188039.16. [Q149M9-3]
DR   Ensembl; ENST00000438489.6; ENSP00000400248.2; ENSG00000188039.16. [Q149M9-2]
DR   Ensembl; ENST00000524140.7; ENSP00000428579.2; ENSG00000188039.16. [Q149M9-3]
DR   Ensembl; ENST00000552788.1; ENSP00000447224.1; ENSG00000188039.16. [Q149M9-1]
DR   Ensembl; ENST00000646016.2; ENSP00000496092.2; ENSG00000188039.16. [Q149M9-2]
DR   Ensembl; ENST00000673803.1; ENSP00000501265.1; ENSG00000188039.16. [Q149M9-3]
DR   GeneID; 284434; -.
DR   KEGG; hsa:284434; -.
DR   MANE-Select; ENST00000524140.7; ENSP00000428579.2; NM_001007525.5; NP_001007526.3. [Q149M9-3]
DR   UCSC; uc002neu.5; human. [Q149M9-1]
DR   AGR; HGNC:27619; -.
DR   CTD; 284434; -.
DR   DisGeNET; 284434; -.
DR   GeneCards; NWD1; -.
DR   HGNC; HGNC:27619; NWD1.
DR   HPA; ENSG00000188039; Tissue enriched (choroid).
DR   MIM; 616250; gene.
DR   neXtProt; NX_Q149M9; -.
DR   OpenTargets; ENSG00000188039; -.
DR   VEuPathDB; HostDB:ENSG00000188039; -.
DR   eggNOG; KOG0265; Eukaryota.
DR   eggNOG; KOG3602; Eukaryota.
DR   GeneTree; ENSGT00940000161635; -.
DR   HOGENOM; CLU_2653829_0_0_1; -.
DR   InParanoid; Q149M9; -.
DR   OMA; YHWSVIE; -.
DR   OrthoDB; 2910252at2759; -.
DR   PhylomeDB; Q149M9; -.
DR   TreeFam; TF332647; -.
DR   PathwayCommons; Q149M9; -.
DR   SignaLink; Q149M9; -.
DR   BioGRID-ORCS; 284434; 12 hits in 1140 CRISPR screens.
DR   ChiTaRS; NWD1; human.
DR   GeneWiki; NWD1; -.
DR   GenomeRNAi; 284434; -.
DR   Pharos; Q149M9; Tdark.
DR   PRO; PR:Q149M9; -.
DR   Proteomes; UP000005640; Chromosome 19.
DR   RNAct; Q149M9; protein.
DR   Bgee; ENSG00000188039; Expressed in olfactory segment of nasal mucosa and 79 other tissues.
DR   ExpressionAtlas; Q149M9; baseline and differential.
DR   GO; GO:0005829; C:cytosol; IDA:UniProtKB.
DR   GO; GO:0005730; C:nucleolus; IDA:HPA.
DR   GO; GO:0005524; F:ATP binding; IEA:UniProtKB-KW.
DR   GO; GO:0032088; P:negative regulation of NF-kappaB transcription factor activity; IMP:UniProtKB.
DR   GO; GO:0010628; P:positive regulation of gene expression; IMP:UniProtKB.
DR   Gene3D; 3.40.50.300; P-loop containing nucleotide triphosphate hydrolases; 1.
DR   Gene3D; 2.130.10.10; YVTN repeat-like/Quinoprotein amine dehydrogenase; 4.
DR   InterPro; IPR007111; NACHT_NTPase.
DR   InterPro; IPR043365; NWD1.
DR   InterPro; IPR027417; P-loop_NTPase.
DR   InterPro; IPR011047; Quinoprotein_ADH-like_supfam.
DR   InterPro; IPR015943; WD40/YVTN_repeat-like_dom_sf.
DR   InterPro; IPR001680; WD40_repeat.
DR   InterPro; IPR019775; WD40_repeat_CS.
DR   PANTHER; PTHR45013; NACHT DOMAIN- AND WD REPEAT-CONTAINING PROTEIN 1; 1.
DR   PANTHER; PTHR45013:SF1; NACHT DOMAIN- AND WD REPEAT-CONTAINING PROTEIN 1; 1.
DR   Pfam; PF05729; NACHT; 1.
DR   Pfam; PF00400; WD40; 3.
DR   SMART; SM00320; WD40; 11.
DR   SUPFAM; SSF52540; P-loop containing nucleoside triphosphate hydrolases; 1.
DR   SUPFAM; SSF50998; Quinoprotein alcohol dehydrogenase-like; 2.
DR   PROSITE; PS00678; WD_REPEATS_1; 2.
DR   PROSITE; PS50082; WD_REPEATS_2; 4.
DR   PROSITE; PS50294; WD_REPEATS_REGION; 3.
PE   1: Evidence at protein level;
KW   Alternative splicing; ATP-binding; Cytoplasm; Nucleotide-binding;
KW   Reference proteome; Repeat; WD repeat.
FT   CHAIN           1..1564
FT                   /note="NACHT domain- and WD repeat-containing protein 1"
FT                   /id="PRO_0000308254"
FT   DOMAIN          335..661
FT                   /note="NACHT"
FT   REPEAT          866..905
FT                   /note="WD 1"
FT   REPEAT          908..947
FT                   /note="WD 2"
FT   REPEAT          956..994
FT                   /note="WD 3"
FT   REPEAT          998..1037
FT                   /note="WD 4"
FT   REPEAT          1044..1082
FT                   /note="WD 5"
FT   REPEAT          1083..1121
FT                   /note="WD 6"
FT   REPEAT          1126..1165
FT                   /note="WD 7"
FT   REPEAT          1167..1207
FT                   /note="WD 8"
FT   REPEAT          1212..1251
FT                   /note="WD 9"
FT   REPEAT          1253..1290
FT                   /note="WD 10"
FT   REPEAT          1291..1327
FT                   /note="WD 11"
FT   REPEAT          1338..1376
FT                   /note="WD 12"
FT   REPEAT          1380..1418
FT                   /note="WD 13"
FT   REPEAT          1425..1462
FT                   /note="WD 14"
FT   BINDING         341..348
FT                   /ligand="ATP"
FT                   /ligand_id="ChEBI:CHEBI:30616"
FT                   /evidence="ECO:0000255"
FT   VAR_SEQ         67..76
FT                   /note="ALIGDQYGPC -> EKCADPCPGQ (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_040651"
FT   VAR_SEQ         77..1564
FT                   /note="Missing (in isoform 2)"
FT                   /evidence="ECO:0000303|PubMed:15489334"
FT                   /id="VSP_040652"
FT   VAR_SEQ         1430..1432
FT                   /note="SSY -> APC (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_028940"
FT   VAR_SEQ         1433..1564
FT                   /note="Missing (in isoform 3)"
FT                   /evidence="ECO:0000303|PubMed:17974005"
FT                   /id="VSP_028941"
FT   VARIANT         174
FT                   /note="S -> G (in dbSNP:rs3888834)"
FT                   /evidence="ECO:0000269|PubMed:17974005"
FT                   /id="VAR_036769"
FT   VARIANT         211
FT                   /note="L -> F (in dbSNP:rs11668502)"
FT                   /id="VAR_036770"
FT   VARIANT         218
FT                   /note="A -> T (in dbSNP:rs706764)"
FT                   /evidence="ECO:0000269|PubMed:17974005"
FT                   /id="VAR_036771"
FT   VARIANT         900
FT                   /note="Q -> E (in dbSNP:rs773930)"
FT                   /id="VAR_036772"
FT   VARIANT         926
FT                   /note="N -> I (in dbSNP:rs2608737)"
FT                   /evidence="ECO:0000269|PubMed:17974005"
FT                   /id="VAR_036773"
FT   VARIANT         935
FT                   /note="H -> R (in dbSNP:rs2608738)"
FT                   /id="VAR_036774"
FT   VARIANT         1541
FT                   /note="D -> V (in dbSNP:rs11671361)"
FT                   /id="VAR_036775"
FT   CONFLICT        15
FT                   /note="C -> F (in Ref. 1; CAH18655)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        78
FT                   /note="I -> V (in Ref. 1; CAH18655)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        994
FT                   /note="H -> Y (in Ref. 1; CAH18655)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1056
FT                   /note="K -> R (in Ref. 1; CAH18655)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1141
FT                   /note="N -> S (in Ref. 1; CAH18655)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1171
FT                   /note="G -> R (in Ref. 1; CAH18655)"
FT                   /evidence="ECO:0000305"
FT   CONFLICT        1399
FT                   /note="K -> R (in Ref. 1; CAH18655)"
FT                   /evidence="ECO:0000305"
SQ   SEQUENCE   1564 AA;  174552 MW;  AB77411A1D6FBCFF CRC64;
     MQRGKPCRAL PTLKCQTFCQ RHGLMFEVVD LRWGIRNIEA TDHLTTELCL EEVDRCWKTS
     IGPAFVALIG DQYGPCLIPS RIDEKEWEVL RDHLTARPSD LELVARYFQR DENAFPPTYV
     LQAPGTGEAC EPEEATLTSV LRSGAQEARR LGLITQEQWQ HYHRSVIEWE IERSLLSSED
     REQGATVFLR EIQDLHKHIL EDCALRMVDR LADGCLDADA QNLLSSLKSH ITDMHPGVLK
     THRLPWSRDL VNPKNKTHAC YLKELGEQFV VRANHQVLTR LRELDTAGQE LAWLYQEIRH
     HLWQSSEVIQ TFCGRQELLA RLGQQLRHDD SKQHTPLVLF GPPGIGKTAL MCKLAEQMPR
     LLGHKTVTVL RLLGTSQMSS DARGLLKSIC FQVCLAYGLP LPPAQVLDAH TRVVQFFHTL
     LHTVSCRNFE SLVLLLDAMD DLDSVRHARR VPWLPLNCPP RVHLILSACS GALGVLDTLQ
     RVLLDPEAYW EVKPLSGNQG QQMIQLLLAA ARRTLSPVHT DLLWASLPEC GNPGRLRLAF
     EEARKWASFT VPVPLATTAE EATHQLCTRL EQTHGQLLVA HVLGYIVSSR HGLSEAELKD
     VLSLDDEVLQ DVYRDWTPPS KELLRFPPLL WVRLRRDLGY YLARRPVDGF TLLAIAHRQL
     VEVVRERYLS GSERAKRHGV LADFFSGTWS QGTKKLITLP LVGKPLNLDR KVAPQPLWFS
     HTVANLRKLK ELPYHLLHSG RLEELKQEVL GSMSWISCRG ISGGIEDLLD DFDLCAPHLD
     SPEVGLVREA LQLCRPAVEL RGMERSLLYT ELLARLHFFA TSHPALVGQL CQQAQSWFQL
     CAHPVLVPLG GFLQPPGGPL RATLSGCHKG ITAMAWGVEE KLLVIGTQDG IMAVWDMEEQ
     HVIHMLTGHT GEVRCVKIFA KGTLANSASK DYTLHLWNLL SGQEKFTIWD GGSKNPAEPQ
     IWNLHVDEAH KVVYSASGSK INAWNLETAE PVFHILGDAS DPWMCMAVLA SQATLLTVSR
     DGVVSLWSSA TGKLQGKQHM SSIKEETPTC AVSVQKQGKL VTGFSNGSIS LVSSKGDRLL
     EKLPDAVRFL VVSEDESLLA AGFGRSVRIF LADSRGFRRF MAMDLEHEDM VETAVFGTEN
     NLIITGSLDA LIQVWSLSEQ GTLLDILEGV GAPVSLLARG GALVASASPQ SSSFKVWDLS
     DAHRSRVPAP FLDRTGLTAV SHNGSYVYFP KIGDKNKVTI WDLAEGEEQD SLDTSSEIRC
     LEVAEQRKLL FTGLVSGVVL VFPLNSRQDV ICIPPPEARK AINCMSLSKC EDRLAIAYDN
     IVLVLDITSG DPCPVIDGPR YTFYTQLPET LSSVAILTDY RVVYSMTNGD LFLYECATSK
     AFPLETHRSR VACVEVSHKE QLVVSGSEDA LLCLWDLQAR KWKFEMSYTS SYCRGVQCAC
     FSKDDKYVYV GLKDRSILVW SVLDGTLLTV QFVHAVVNRI IPTTSGFIAP TRHGYLIREN
     FQCLSAKASP QDPLKNFKKA MWMVKSRQRE ELVAAAGAPQ DLESESAQGN ETKSNKCSQV
     CLIV
//
